News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ocular Therapeutix, Inc. Adds $6 Million to C Round



1/13/2011 7:44:40 AM

Xconomy -- Ocular Therapeutix, a Bedford, MA-based developer of therapies for the eye, has brought in an additional $6 million for its Series C round, which now totals $21 million, company co-founder and CEO Amar Sawhney confirmed via e-mail today.

Read at Xconomy


comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES